rhTSH-aided Low-Activity Versus High-Activity Regimens of Radioiodine in Residual Ablation for Differentiated Thyroid Cancer

Nuclear Medicine Communications - United States
doi 10.1097/mnm.0b013e328365ac05
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)